Physician profile
Raju Thomas
NPI 1093809360
$66,798.32
in general payments reported to CMS, 2019-2025
42 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $8,896 · 2021: $1,825 · 2022: $10K · 2023: $1,152 · 2024: $12K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $22K · Food and Beverage: $2,628 · Travel and Lodging: $1,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $21,929.38 |
| Food and Beverage | $2,628.28 |
| Travel and Lodging | $1,897.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $42,095.32 | 2019-2025 | Uropass, Gyrus Acmi, Uretero-Reno Fiberscope |
| Karl Storz Endoscopy-America | $10,329.71 | 2019-2023 | Flex-X |
| Gyrus Acmi, INC. | $7,330.84 | 2019 | |
| Intuitive Surgical, INC. | $2,393.16 | 2019-2023 | Da Vinci Surgical System |
| Boston Scientific Corporation | $744.65 | 2019-2025 | Lithovue, Naviguide |
| Astellas Pharma US INC | $488.11 | 2019-2025 | Padcev |
| Ethicon INC. | $447.29 | 2021 | |
| Coloplast Corp | $338.11 | 2020-2025 | Titan, Altis |
| Cook Medical LLC | $227.42 | 2019-2025 | Litho 150 |
| Olympus America INC. | $224.69 | 2019-2024 | Itind System |
| Urogen Pharma, INC. | $220.15 | 2022-2024 | |
| Procept Biorobotics Corporation | $166.44 | 2024 | Aquabeam System |
| Covidien LP | $160.80 | 2019 | |
| Teleflex LLC | $160.10 | 2020-2024 | |
| Dendreon Pharmaceuticals LLC | $139.86 | 2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $126.86 | 2022 | |
| Medtronic, INC. | $120.47 | 2023 | Interstim |
| Progenics Pharmaceuticals, INC. | $113.73 | 2021-2023 | Pylarify |
| Angiodynamics, INC. | $110.40 | 2025 | Angiovac |
| Conmed Corporation | $108.88 | 2019 | |
| Koelis INC. | $78.96 | 2024 | |
| Merck Sharp & Dohme LLC | $62.28 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $57.40 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $57.00 | 2022-2024 | |
| Innovation Technologies INC | $56.01 | 2025 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $53.84 | 2025 | Imfinzi |
| Sumitomo Pharma America, INC. | $48.18 | 2023-2025 | Gemtesa |
| Endo USA, INC. | $45.93 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $42.12 | 2022 | |
| Genzyme Corporation | $36.58 | 2019 | |
| Photocure INC | $31.24 | 2025 | Cysview |
| Bluewind Medical | $28.33 | 2024 | Revi |
| Profound Medical Corp. | $27.36 | 2025 | Tulsa-Pro |
| Myriad Genetic Laboratories, INC. | $21.77 | 2021 | |
| Lsi Solutions INC | $21.70 | 2025 | Running Device, Ti-Knot, Jnw Urtrac |
| Myovant Sciences INC. | $20.02 | 2022 | |
| Janssen Biotech, INC. | $16.83 | 2025 | Erleada |
| Jazz Pharmaceuticals INC. | $16.64 | 2022 | |
| Travere Therapeutics, INC. | $14.83 | 2022-2025 | Thiola |
| Civco Medical Instruments | $14.31 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raju Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.